The ID NOW rapid test is used in urgent care settings where people need results fast. The test shows results in as little as 13 minutes, helping to identify SARS-CoV-2 before it spreads. Abbott has shipped 1.8 million tests for COVID-19 and 15 complaints have been reported to FDA in real-world situations. The test is in use in 1,000+ locations across the U.S. A new study by a leading COVID-19 researcher found 91% sensitivity with 100% specificity.
To help meet the needs of patients and healthcare providers affected by the coronavirus outbreak in China, Abbott donated diagnostics, nutrition products and funding. Donations include the ARCHITECT c8000 clinical chemistry system, which runs high-volume diagnostic tests to monitor patient health; the i-STAT handheld blood analyzer system, which provides healthcare workers with fast diagnostic test results to monitor patient health by their bedside; Ensure Complete, PediaSure, Pedialyte and other Abbott nutrition products for patients and medical professionals; and funding for the purchase of medical necessities including protective suits, masks and disinfectant.